These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 35172189)
1. Depression-free after interferon-a exposure indicates less incidence of depressive disorder: A longitudinal study in Taiwan. Liu PS; Liaw YP Brain Behav Immun; 2022 May; 102():88. PubMed ID: 35172189 [No Abstract] [Full Text] [Related]
2. Does the decreased incidence of new-onset depression in patients with interferon-α therapy indicate the protective effect of interferon-α against depression? Saito T; Ikeda M; Hashimoto S; Iwata N Brain Behav Immun; 2021 May; 94():471. PubMed ID: 33631286 [No Abstract] [Full Text] [Related]
3. Reply to "Does the decreased incidence of new-onset depression in patients with interferon-α therapy indicate the protective effect of interferon-α against depression?". Sun CF; Chiu WC; Su KP Brain Behav Immun; 2021 May; 94():472. PubMed ID: 33639238 [No Abstract] [Full Text] [Related]
4. Somatic symptoms in inflammation-related depression: Reply to "Letter for depression-free after interferon-α exposure indicates less incidence of depressive disorder: A longitudinal study in Taiwan". Sun CF; Chiu WC; Su KP Brain Behav Immun; 2022 May; 102():161-162. PubMed ID: 35172190 [No Abstract] [Full Text] [Related]
5. Depression-free after Interferon-α exposure indicates less incidence of depressive disorder: A longitudinal study in Taiwan. Sun CF; Chiu WC; Chen PC; Chang HC; Guu TW; Shityakov S; Miller AH; Felger JC; Chang JP; Su KP Brain Behav Immun; 2020 Aug; 88():125-131. PubMed ID: 32434045 [TBL] [Abstract][Full Text] [Related]
6. Recurrence of depressive disorders after interferon-induced depression. Chiu WC; Su YP; Su KP; Chen PC Transl Psychiatry; 2017 Feb; 7(2):e1026. PubMed ID: 28170005 [TBL] [Abstract][Full Text] [Related]
8. Asymmetric dimethylarginine responses during interferon-α-induced depression in patients with chronic hepatitis C infection. Baranyi A; Meinitzer A; Putz-Bankuti C; Stauber R; Kapfhammer HP; Rothenhäusler HB Psychosom Med; 2014 Apr; 76(3):197-207. PubMed ID: 24608038 [TBL] [Abstract][Full Text] [Related]
9. [Depressive disturbances during antiviral therapy in patients with type C hepatitis]. Ignatova TM; Kinkul'kina MA; Morozov AO; Avdeeva TI; Volkov AV; Tikhonova IuG Klin Med (Mosk); 2007; 85(7):58-63. PubMed ID: 17882814 [TBL] [Abstract][Full Text] [Related]
10. Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy. Kraus MR; Schäfer A; Faller H; Csef H; Scheurlen M J Clin Psychiatry; 2003 Jun; 64(6):708-14. PubMed ID: 12823087 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C, alpha interferon, anxiety and depression disorders: a prospective study of 71 patients. Gohier B; Goeb JL; Rannou-Dubas K; Fouchard I; Calès P; Garré JB World J Biol Psychiatry; 2003 Jul; 4(3):115-8. PubMed ID: 12872204 [TBL] [Abstract][Full Text] [Related]
12. Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus. Bonaccorso S; Marino V; Biondi M; Grimaldi F; Ippoliti F; Maes M J Affect Disord; 2002 Dec; 72(3):237-41. PubMed ID: 12450640 [TBL] [Abstract][Full Text] [Related]
13. Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C. Raison CL; Broadwell SD; Borisov AS; Manatunga AK; Capuron L; Woolwine BJ; Jacobson IM; Nemeroff CB; Miller AH Brain Behav Immun; 2005 Jan; 19(1):23-7. PubMed ID: 15581735 [TBL] [Abstract][Full Text] [Related]
14. Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. Udina M; Castellví P; Moreno-España J; Navinés R; Valdés M; Forns X; Langohr K; Solà R; Vieta E; Martín-Santos R J Clin Psychiatry; 2012 Aug; 73(8):1128-38. PubMed ID: 22967776 [TBL] [Abstract][Full Text] [Related]
15. Depression during therapy with interferon alpha--how long should an antidepressant treatment last? Nickel T; Sonntag A; Backmund M; Pollmächer T Pharmacopsychiatry; 2005 Mar; 38(2):102-4. PubMed ID: 15744637 [TBL] [Abstract][Full Text] [Related]
16. Depressive symptoms in patients with hepatitis C treated with pegylated interferon alpha therapy: a 24-week prospective study. Pavlović Z; Delić D; Marić NP; Vuković O; Jašović-Gašić M Psychiatr Danub; 2011 Dec; 23(4):370-7. PubMed ID: 22075738 [TBL] [Abstract][Full Text] [Related]
17. A quantitative assessment of depression and thyroid dysfunction secondary to interferon-alpha therapy in patients with hepatitis C. Loftis JM; Wall JM; Linardatos E; Benvenga S; Hauser P J Endocrinol Invest; 2004; 27(7):RC16-20. PubMed ID: 15505982 [TBL] [Abstract][Full Text] [Related]
18. Incidence and clinical course of major depression in patients with chronic hepatitis type C undergoing interferon-alpha therapy: a prospective study. Horikawa N; Yamazaki T; Izumi N; Uchihara M Gen Hosp Psychiatry; 2003; 25(1):34-8. PubMed ID: 12583926 [TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha-induced depression: Comparisons between early- and late-onset subgroups and with patients with major depressive disorder. Su KP; Lai HC; Peng CY; Su WP; Chang JP; Pariante CM Brain Behav Immun; 2019 Aug; 80():512-518. PubMed ID: 31059806 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus infection in Taiwan: Past, present, and future. Kao JH J Formos Med Assoc; 2016 Feb; 115(2):65-6. PubMed ID: 26228687 [No Abstract] [Full Text] [Related] [Next] [New Search]